Extract from the Register of European Patents

EP About this file: EP2483305

EP2483305 - MULTISTEP FINAL FILTRATION OF IMMUNOGLOBULIN [Right-click to bookmark this link]
Former [2012/32]MULTISTEP FINAL FILTRATION
[2016/22]
StatusNo opposition filed within time limit
Status updated on  28.07.2017
Database last updated on 09.04.2026
Most recent event   Tooltip19.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 21.11.2018  [2018/47]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2012/32]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / FALKENSTEIN, Roberto
Wastl-Witt-Strasse 5
80689 Muenchen / DE
02 / SCHWENDNER, Klaus
Am Obstgarten 47
82362 Weilheim / DE
 [2012/32]
Representative(s)Burger, Alexander, et al
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[N/P]
Former [2012/32]Burger, Alexander, et al
Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52
82372 Penzberg / DE
Application number, filing date10757795.929.09.2010
[2016/38]
WO2010EP64487
Priority number, dateEP2009001246001.10.2009         Original published format: EP 09012460
[2012/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011039274
Date:07.04.2011
Language:EN
[2011/14]
Type: A1 Application with search report 
No.:EP2483305
Date:08.08.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 07.04.2011 takes the place of the publication of the European patent application.
[2012/32]
Type: B1 Patent specification 
No.:EP2483305
Date:21.09.2016
Language:EN
[2016/38]
Search report(s)International search report - published on:EP07.04.2011
ClassificationIPC:C07K16/06, C07K16/28, C07K16/32
[2016/22]
CPC:
C07K16/065 (EP,KR,US); C07K1/16 (KR); C07K1/34 (KR);
C07K1/36 (KR); C07K16/2866 (EP,KR,US); C07K16/32 (EP,KR,US)
Former IPC [2012/32]C07K16/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/32]
Extension statesBANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:ENDGÜLTIGE FILTRIERUNG VON IMMUNOGLOBULIN IN MEHREREN SCHRITTEN[2016/24]
English:MULTISTEP FINAL FILTRATION OF IMMUNOGLOBULIN[2016/22]
French:FILTRATION FINALS D'UNE PRÉPARATION D'IMMUNOGLOBULINE EN PLUSIEURS ÉTAPES[2016/22]
Former [2012/32]ENDFILTRIERUNG IN MEHREREN SCHRITTEN
Former [2012/32]MULTISTEP FINAL FILTRATION
Former [2012/32]FILTRATION FINALE À MULTIPLES ÉTAPES
Entry into regional phase02.05.2012National basic fee paid 
02.05.2012Designation fee(s) paid 
02.05.2012Examination fee paid 
Examination procedure02.05.2012Examination requested  [2012/32]
30.11.2012Amendment by applicant (claims and/or description)
04.08.2014Despatch of a communication from the examining division (Time limit: M04)
30.10.2014Reply to a communication from the examining division
22.09.2015Despatch of a communication from the examining division (Time limit: M06)
23.02.2016Reply to a communication from the examining division
19.05.2016Communication of intention to grant the patent
02.08.2016Fee for grant paid
02.08.2016Fee for publishing/printing paid
02.08.2016Receipt of the translation of the claim(s)
Divisional application(s)EP16188558.7  / EP3133083
EP20156152.9
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.08.2014
Opposition(s)22.06.2017No opposition filed within time limit [2017/35]
Fees paidRenewal fee
26.09.2012Renewal fee patent year 03
09.09.2013Renewal fee patent year 04
08.09.2014Renewal fee patent year 05
08.09.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL21.09.2016
MK21.09.2016
SM21.09.2016
IS21.01.2017
[2018/47]
Former [2018/30]MK21.09.2016
SM21.09.2016
IS21.01.2017
Former [2017/34]SM21.09.2016
IS21.01.2017
Cited inInternational search[Y] WO2009010269  (HOFFMANN LA ROCHE et al.)
 [A] US4592848  (PABST RICHARD E et al.)
 [Y]   ALDINGTON ET AL: "Scale-up of monoclonal antibody purification processes", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES & APPLICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 848, no. 1, 12 March 2007 (2007-03-12), pages 64 - 78, XP005922828, ISSN: 1570-0232

DOI:   http://dx.doi.org/10.1016/j.jchromb.2006.11.032
 [A]   HONIG ET AL: "Impact of design and selection of prefilters on operating cost", FILTRATION AND SEPARATION, ELSEVIER ADVANCED TECHNOLOGY, OXFORD, GB, vol. 34, no. 1, 1 January 1997 (1997-01-01), pages 73 - 78, XP005635274, ISSN: 0015-1882

DOI:   http://dx.doi.org/10.1016/S0015-1882(97)84825-2
ExaminationCS247484
   ANONYMOUS: "Laboratory Procedure Manual", 1 January 2004 (2004-01-01), XP055131817, Retrieved from the Internet [retrieved on 20140728]
   ANONYMOUS: "waybackmachine for http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l06_b_met_ferritin.pdf", 28 July 2014 (2014-07-28), XP055131833, Retrieved from the Internet [retrieved on 20140728] [P]
by applicantDE4204444
 US4488961
 US5643566
 EP0204836
 DE3818860
 CS247484
 WO2006072564
 WO9222653
 WO9957134
 WO9704801
 US5677171
 US5821337
   ALDINGTON ET AL., J. CHROM. B, vol. 848, 2007, pages 64 - 78
   VIJAYALAKSHMI, M. A., APPL. BIOCHEM. BIOTECH., vol. 75, 1998, pages 93 - 102
   MERRICK, H.; HAWLITSCHEK, G., BIOTECH FORUM EUROPE, vol. 9, 1992, pages 398 - 403
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.